Published in Proteomics on August 01, 2002
Anucleate platelets generate progeny. Blood (2010) 2.24
Molecular targets for anti-oxidative protection of green tea polyphenols against myocardial ischemic injury. Biomedicine (Taipei) (2014) 0.98
Selection of reference genes in different myocardial regions of an in vivo ischemia/reperfusion rat model for normalization of antioxidant gene expression. BMC Res Notes (2012) 0.87
Activation of signaling pathways and regulatory mechanisms of mRNA translation following myocardial ischemia-reperfusion. J Appl Physiol (1985) (2006) 0.84
Microarray and proteomic analysis of the cardioprotective effects of cold blood cardioplegia in the mature and aged male and female. Physiol Genomics (2012) 0.81
DIGE proteome analysis reveals suitability of ischemic cardiac in vitro model for studying cellular response to acute ischemia and regeneration. PLoS One (2012) 0.79
Novel O-palmitolylated beta-E1 subunit of pyruvate dehydrogenase is phosphorylated during ischemia/reperfusion injury. Proteome Sci (2010) 0.76
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med (2015) 13.90
Bivalirudin for patients with acute coronary syndromes. N Engl J Med (2006) 5.49
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis (2004) 3.55
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation (2013) 3.44
Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation (2009) 3.28
Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation (2002) 3.20
Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem (2005) 3.06
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation (2003) 2.89
Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med (2003) 2.87
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation (2013) 2.64
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial. Ann Intern Med (2011) 2.45
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med (2006) 2.39
Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry (2009) 2.31
Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation (2002) 2.20
Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation (2002) 2.18
Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan. Crit Care Med (2009) 2.16
CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost (2004) 2.09
Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med (2005) 1.99
Intravascular embolization of venous catheter--causes, clinical signs, and management: a systematic review. JPEN J Parenter Enteral Nutr (2009) 1.94
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med (2010) 1.84
Intravenous port catheter embolization: mechanisms, clinical features, and management. Angiology (2008) 1.78
Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. Circulation (2009) 1.76
Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids. Pain (2009) 1.74
Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury. J Cardiovasc Electrophysiol (2007) 1.73
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation (2004) 1.73
The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus. Nat Med (2012) 1.72
Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome. Crit Care Med (2008) 1.66
Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J Rheumatol (2004) 1.58
Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J (2004) 1.58
Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators. Circulation (2003) 1.57
Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study. Cerebrovasc Dis (2010) 1.55
Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci (2008) 1.54
Predictors of treatment in acute coronary syndromes in the elderly: impact on decision making and clinical outcome after interventional versus conservative treatment. Catheter Cardiovasc Interv (2012) 1.53
Association of low ankle brachial index with high mortality in primary care. Eur Heart J (2006) 1.53
Microcircuits of functionally identified neurons in the rat medial entorhinal cortex. Neuron (2011) 1.51
Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab. J Am Coll Cardiol (2003) 1.44
Schizophrenia and depression: challenging the paradigm of two separate diseases--a controlled study of schizophrenia, depression and healthy controls. Schizophr Res (2005) 1.44
The German CPU Registry: comparison of troponin positive to troponin negative patients. Int J Cardiol (2013) 1.43
Transcoronary pacing in a porcine model--impact of guidewire insulation. J Invasive Cardiol (2011) 1.42
Magnetic resonance imaging of coronary artery occlusions in the navigator technique. Int J Cardiovasc Imaging (2002) 1.42
Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused rat hearts. Crit Care Med (2003) 1.41
Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX). Crit Care Med (2015) 1.40
Impact of infectious burden on progression of carotid atherosclerosis. Stroke (2002) 1.40
Rescue-stenting of an occluded lateral coronary sinus branch for recanalization after dissection during cardiac resynchronization device implantation. Europace (2008) 1.38
Vaccine immunogenicity in injecting drug users. Lancet Infect Dis (2009) 1.37
Thrombolytic therapy in pregnancy. J Thromb Thrombolysis (2006) 1.36
Septic cardiomyopathy - A not yet discovered cardiomyopathy? Exp Clin Cardiol (2006) 1.36
Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol (2003) 1.34
Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease. J Am Coll Cardiol (2003) 1.32
Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J (2005) 1.31
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol (2010) 1.27
The septation apparatus, an autonomous system in budding yeast. Mol Biol Cell (2002) 1.26
Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. JACC Cardiovasc Interv (2011) 1.26
Abeta-globulomers are formed independently of the fibril pathway. Neurobiol Dis (2008) 1.23
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr Metab (Lond) (2006) 1.20
Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol (2002) 1.15
Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med (2006) 1.15
Quantification of shunt volumes in congenital heart diseases using a breath-hold MR phase contrast technique--comparison with oximetry. Int J Cardiovasc Imaging (2002) 1.14
Activated polymorphonuclear leukocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events. J Exp Med (2004) 1.13
Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun (2008) 1.13
Tumor tracking and motion compensation with an adaptive tumor tracking system (ATTS): system description and prototype testing. Med Phys (2008) 1.11
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial. Circ Cardiovasc Interv (2012) 1.11
Port catheter insufficiency: incidence and clinical-radiological correlations. Onkologie (2008) 1.11
Morphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: the role of other discriminators. J Cardiovasc Electrophysiol (2014) 1.08
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol (2012) 1.07
The early course of schizophrenia and depression*. Eur Arch Psychiatry Clin Neurosci (2005) 1.07
Magnet application in ICD patients. Pacing Clin Electrophysiol (2014) 1.07
Profound influence of different methods for determination of the ankle brachial index on the prevalence estimate of peripheral arterial disease. BMC Public Health (2007) 1.06
Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int (2012) 1.06
Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol (2003) 1.03
Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock (2008) 1.03
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med (2008) 1.03
Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor. Proteomics (2007) 1.01
Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock. Crit Care Med (2002) 0.99
Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system. Int J Cardiol (2011) 0.99
Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. Am J Cardiol (2002) 0.99
Myocardium: dynamic versus single-shot CT perfusion imaging. Radiology (2013) 0.99
Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism. Structure (2002) 0.98
Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs. Yeast (2006) 0.97
Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis. J Lipid Res (2003) 0.97
Tranilast inhibits cytokine-induced nuclear factor kappaB activation in vascular endothelial cells. Mol Pharmacol (2002) 0.97
Excess 1-year cardiovascular risk in elderly primary care patients with a low ankle-brachial index (ABI) and high homocysteine level. Atherosclerosis (2005) 0.96
Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry. Thromb Haemost (2014) 0.96
Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J Antimicrob Chemother (2008) 0.96
Pulmonary vein electrophysiology during cryoballoon ablation as a predictor for procedural success. J Interv Card Electrophysiol (2011) 0.95
Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the "German chest pain unit registry". Clin Res Cardiol (2012) 0.95
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev (2015) 0.95
A control study to evaluate a computer-based microarray experiment design recommendation system for gene-regulation pathways discovery. J Biomed Inform (2005) 0.94
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev (2011) 0.94
Pre-segmented 2-Step IMRT with subsequent direct machine parameter optimisation - a planning study. Radiat Oncol (2008) 0.93